Metabolic activation of nucleoside and nucleotide reverse transcriptase inhibitors in dendritic and Langerhans cellsBALZARINI, Jan; VAN HERREWEGE, Yven; VANHAM, Guido et al.AIDS (London). 2002, Vol 16, Num 16, pp 2159-2163, issn 0269-9370, 5 p.Article

Production of human immunodeficiency virus type 1 (HIV-1) pseudoviruses using linear HIV-1 envelope expression cassettesBEELS, Dominique; HEYNDRICKX, Leo; VEREECKEN, Katleen et al.Journal of virological methods. 2008, Vol 147, Num 1, pp 99-107, issn 0166-0934, 9 p.Article

In vitro pre-and post-exposure prophylaxis using HIV inhibitors as microbicides against cell-free or cell-associated HIV-1 infectionTERRAZAS-ARANDA, Katty; VAN HERREWEGE, Yven; LEWI, Paul J et al.Antiviral chemistry & chemotherapy. 2007, Vol 18, Num 3, pp 141-151, issn 0956-3202, 11 p.Article

What is the significance of posttreatment control of HIV infection vis-à-vis functional cure?VANHAM, Guido; BUVE, Anne; FLORENCE, Eric et al.AIDS (London). 2014, Vol 28, Num 4, pp 603-605, issn 0269-9370, 3 p.Article

Human T-lymphotropic virus 1 : recent knowledge about an ancient infectionVERDONCK, Kristien; GONZALEZ, Elsa; VAN DOOREN, Sonia et al.Lancet. Infectious diseases (print). 2007, Vol 7, Num 4, pp 266-281, issn 1473-3099, 16 p.Article

Inhibition of HIV-1 by non-nucleoside reverse transcriptase inhibitors via an induced fit mechanism—Importance of slow dissociation and relaxation rates for antiviral efficacyELINDER, Malin; SELHORST, Philippe; VANHAM, Guido et al.Biochemical pharmacology. 2010, Vol 80, Num 8, pp 1133-1140, issn 0006-2952, 8 p.Article

Neutralization Patterns and Evolution of Sequential HIV Type 1 Envelope Sequences in HIV Type 1 Subtype B-Infected Drug-Naive IndividualsNYAMBI, Phillipe; BURDA, Sherri; URBANSKI, Mateusz et al.AIDS research and human retroviruses. 2008, Vol 24, Num 12, pp 1507-1519, issn 0889-2229, 13 p.Article

In Vitro Activities of Candidate Microbicides against Cell-Associated HIVSELHORST, Philippe; GRUPPING, Katrijn; BOURIET, Thomas et al.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 2, pp 805-815, issn 0066-4804, 11 p.Article

Possible Implication of NFkB1A and NKG2D Genes in Susceptibility to HTLV-1-Associated Myelopathy/ Tropical Spastic Paraparesis in Peruvian Patients Infected With HTLV-1TALLEDO, Michael; LOPEZ, Giovanni; HUGHE, Jeroen R et al.Journal of medical virology. 2012, Vol 84, Num 2, pp 319-326, issn 0146-6615, 8 p.Article

Human Immunodeficiency Virus Type 1 (HIV-1) Integration : a Potential Target for Microbicides To Prevent Cell-Free or Cell-Associated HIV-1 InfectionTERRAZAS-ARANDA, Katty; VAN HERREWEGE, Yven; HAZUDA, Daria et al.Antimicrobial agents and chemotherapy. 2008, Vol 52, Num 7, pp 2544-2554, issn 0066-4804, 11 p.Article

Development and evaluation of an oligonucleotide ligation assay for detection of drug resistance-associated mutations in the human immunodeficiency virus type 2 pol geneJALLOW, Sabelle; KAYE, Steve; JANSSENS, Wouter et al.Journal of clinical microbiology (Print). 2007, Vol 45, Num 5, pp 1565-1571, issn 0095-1137, 7 p.Article

Neutralization of primary HIV-1 SF13 can be detected in extended incubation phase assays with sera from monkeys immunized with recombinant HIV-1 SF2 gp 120DAVIS, David; DONNERS, Helen; WILLEMS, Betty et al.Vaccine. 2004, Vol 22, Num 5-6, pp 747-754, issn 0264-410X, 8 p.Article

mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patientsVAN GULCK, Ellen; VLIEGHE, Erika; DE HAES, Winni et al.AIDS (London). 2012, Vol 26, Num 4, issn 0269-9370, F1-F12Article

Human Immunodeficiency Virus Type 1 Resistance or Cross-Resistance to Nonnucleoside Reverse Transcriptase Inhibitors Currently under Development as MicrobicidesSELHORST, Philippe; VAZQUEZ, Ana C; TERRAZAS-ARANDA, Katty et al.Antimicrobial agents and chemotherapy. 2011, Vol 55, Num 4, pp 1403-1413, issn 0066-4804, 11 p.Article

Presence of a Multidrug-Resistance Mutation in an HIV-2 Variant Infecting a Treatment-Naive Individual in Caio, Guinea BissauJALLOW, Sabelle; VINCENT, Tim; JAYE, Assan et al.Clinical infectious diseases. 2009, Vol 48, Num 12, pp 1790-1793, issn 1058-4838, 4 p.Article

Simultaneous activation of viral antigen-specific memory CD4⁺ and CD8⁺ T-cells using mRNA-electroporated CD40-activated autologous B-cellsVAN DEN BOSCH, Glenn A; VAN GULCK, Ellen; BERNEMAN, Zwi N et al.Journal of immunotherapy (1997). 2006, Vol 29, Num 5, pp 512-523, issn 1524-9557, 12 p.Article

A series of diaryltriazines and diarylpyrimidines are highly potent nonnucleoside reverse transcriptase inhibitors with possible applications as microbicidesVAN HERREWEGE, Yven; VANHAM, Guido; MICHIELS, Jo et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 10, pp 3684-3689, issn 0066-4804, 6 p.Article

Electrospun polystyrene fibers for HIV entrapmentCHAOBO HUANG; SOENEN, Stefaan J; DEMEESTER, Jo et al.Polymers for advanced technologies. 2014, Vol 25, Num 8, pp 827-834, issn 1042-7147, 8 p.Article

Virological Response to Highly Active Antiretroviral Therapy in Patients Infected with Human Immunodeficiency Virus Type 2 (HTV-2) and in Patients Dually Infected with HIV-1 and HIV-2 in The Gambia and Emergence of Drug-Resistant VariantsJALLOW, Sabelle; ALABI, Abraham; ROWLAND-JONES, Sarah et al.Journal of clinical microbiology (Print). 2009, Vol 47, Num 7, pp 2200-2208, issn 0095-1137, 9 p.Article

In vitro synergistic activity against CCRS-tropic HIV-1 with combinations of potential candidate microbicide molecules HHA, KRV2110 and enfuvirtide (T20)JENABIAN, Mohammad-Ali; SAÏDI, Héla; CHARPENTIER, Charlotte et al.Journal of antimicrobial chemotherapy (Print). 2009, Vol 64, Num 6, pp 1192-1195, issn 0305-7453, 4 p.Article

CD4 mimetic miniproteins : potent anti-HIV compounds with promising activity as microbicidesVAN HERREWEGE, Yven; MORELLATO, Laurence; DESCOURS, Anne et al.Journal of antimicrobial chemotherapy (Print). 2008, Vol 61, Num 4, pp 818-826, issn 0305-7453, 9 p.Article

SYBR Green-based quantitation of human T-lymphotropic virus type 1 proviral load in peruvian patients with neurological disease and asymptomatic carriers : Influence of clinical status, sex, and familial relatednessADAUI, Vanessa; VERDONCK, Kristien; BEST, Ivan et al.Journal of neurovirology. 2006, Vol 12, Num 6, pp 456-465, issn 1355-0284, 10 p.Article

Role of baseline pol genotype in HIV-1 fitness evolutionWEBER, Jan; RANGEL, Hector R; LANDAY, Alan et al.Journal of acquired immune deficiency syndromes (1999). 2003, Vol 33, Num 4, pp 448-460, issn 1525-4135, 13 p.Article

Lipoplexes carrying mRNA encoding Gag protein modulate dendritic cells to stimulate HIV-specific immune responsesDE HAES, Winni; REJMAN, Joanna; VAN GULCK, Ellen et al.Nanomedicine (London. Print). 2013, Vol 8, Num 1, pp 77-87, issn 1743-5889, 11 p.Article

Polymeric Nanoparticles Affect the Intracellular Delivery, Antiretroviral Activity and Cytotoxicity of the Microbicide Drug Candidate DapivirineDAS NEVES, Jose; MICHIELS, Johan; ARIËN, Kevin K et al.Pharmaceutical research. 2012, Vol 29, Num 6, pp 1468-1484, issn 0724-8741, 17 p.Article